Health TrialsbyHealthPanel

Microbiological Characterization and Antibiotic Resistance Profiling of Providencia Spp,: An Emerging Pathogen Isolated From Urinary Tract Infections

ConditionUrinary Tract Infection
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorAssiut University

About this trial

Aims of the Research:

1. Isolation and identification of Providencia spp. from UTIs. 2. Genotypic confirmation of Providencia isolates. 3. Determination of antimicrobial sensitivity patterns of isolated Providencia spp. 4. Characterization of some virulence factors of Providencia spp. 5. Molecular characterization of multidrug-resistance gene antibiotics. 6. Determination of risk factors for Providencia UTIs.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

None

Disqualifiers

Patients currently on antibiotics.

Patients with any anatomical abnormalities in the urinary tract C) Patients having UTI by gram +ve organisms.

Trial population

Patients with UTI diagnosed through clinical examination and urine analysis.

Trial design

Design model

Other

Time perspective

Cross-sectional

Treatments tested in this trial

  • Antibiotic sensitivity

    Drug

    Molecular characterization of multidrug-resistance gene antibiotics.

Treatment groups

No treatment groups listed

Trial outcomes

Primary outcomes

1

Determination of prevalence of Providencia species refers specifically to urinary tract infection patients with gram-negative bacterial isolates.

Time frame
Through study completion, an average of 1 year

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Assiut University

Lead sponsor

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: